Dr Ian Doyle
Ian’s early research focused on kidney stone formation, and his discovery of the “crystal matrix protein” has redirected the focus of kidney stone research worldwide. Subsequently, Ian switched to respiratory research, where he has become a leader in his field. Ian’s work with Andrew Bersten on acute respiratory distress syndrome has resulted in internationally acclaimed publications. This research has also led to development of a patented test for lung health, with Ian listed officially as “inventor”.